Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vasectomies Produce Abnormal Sperm

By HospiMedica staff writers
Posted on 07 Jul 2006
A new study has found that men who have a vasectomy reversed are more likely to have genetically defective sperm, potentially lowering fertility and influencing the health of their children. More...


Researchers at Chulalongkorn University (Bangkok, Thailand) tested 21 sperm samples from 18 men and found that 3.3% of their sperm had genetic defects, including abnormally high rates of chromosomal defects called sexual aneuploidies. The defects mean that the sperm are also not able to swim as well, making conception less likely. The researchers concluded that a vasectomy, even if it is reversed, makes men ten times more likely to produce sperm with chromosomal abnormalities. Lead author Prof. Nares Sukcharoen believes that a pressure build-up in the vas deferens, disrupting the normal production of sperm in men who have had vasectomies, is the cause of the defects. The research findings were presented at the annual meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in June 2006 in Prague (Czech Republic).

Sexual aneuploidies are defects when sperm have an extra X or Y chromosome, which cause a number of medical conditions in children, such as Klinefelter syndrome, in which boys are born with an extra X chromosome and often develop abnormally proportioned bodies and experience learning difficulties. Another, rarer condition is found in Triple X syndrome, which affects around one in 2,000 girls, and is caused by sperm carrying two X chromosomes instead of the usual one. It can lead to women developing symptoms such as seizures and infertility.

The researchers recommend that men considering a vasectomy freeze some of their sperm before undergoing the procedure.



Related Links:
Chulalongkorn University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.